ZA875897B - Estradiol implant composition and method for preparation - Google Patents

Estradiol implant composition and method for preparation

Info

Publication number
ZA875897B
ZA875897B ZA875897A ZA875897A ZA875897B ZA 875897 B ZA875897 B ZA 875897B ZA 875897 A ZA875897 A ZA 875897A ZA 875897 A ZA875897 A ZA 875897A ZA 875897 B ZA875897 B ZA 875897B
Authority
ZA
South Africa
Prior art keywords
preparation
estradiol
implant composition
time
extended periods
Prior art date
Application number
ZA875897A
Other languages
English (en)
Inventor
Mimi Yih-Pei Chou Schaaf
Yih-Pei Chou Schaaf Mimi
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA875897B publication Critical patent/ZA875897B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
ZA875897A 1986-08-11 1987-08-10 Estradiol implant composition and method for preparation ZA875897B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/895,415 US4758435A (en) 1986-08-11 1986-08-11 Estradiol implant composition and method for preparation

Publications (1)

Publication Number Publication Date
ZA875897B true ZA875897B (en) 1988-05-25

Family

ID=25404471

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA875897A ZA875897B (en) 1986-08-11 1987-08-10 Estradiol implant composition and method for preparation

Country Status (10)

Country Link
US (1) US4758435A (fr)
EP (1) EP0257369B1 (fr)
AT (1) ATE74751T1 (fr)
AU (1) AU599406B2 (fr)
CA (1) CA1297020C (fr)
DE (1) DE3778244D1 (fr)
ES (1) ES2031096T3 (fr)
GR (1) GR3004370T3 (fr)
NZ (1) NZ221390A (fr)
ZA (1) ZA875897B (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
DE3734223A1 (de) * 1987-10-09 1989-04-20 Boehringer Ingelheim Kg Implantierbares, biologisch abbaubares wirkstofffreigabesystem
US5250584A (en) * 1988-08-31 1993-10-05 G-C Dental Industrial Corp. Periodontium-regenerative materials
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
US5198220A (en) * 1989-11-17 1993-03-30 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5350580A (en) * 1990-03-05 1994-09-27 Minnesota Mining And Manufacturing Company Device and method for extended delivery of pharmacologically active agents to the ear
DE69004415D1 (de) * 1990-03-05 1993-12-09 Minnesota Mining & Mfg Vorrichtung zur verzögerten Abgabe von pharmakologisch aktiven Verbindungen ins Ohr.
US5288496A (en) * 1990-05-15 1994-02-22 Stolle Research & Development Corporation Growth promoters for animals
US5643595A (en) * 1992-11-24 1997-07-01 Alkermes Controlled Therapeutics Inc. Ii Growth promoters for animals
FR2756493B1 (fr) * 1996-12-02 2001-04-13 Delab Dispositif d'administration locale de formulations solides ou semi-solides
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
DE19744135C1 (de) * 1997-09-29 1999-03-25 Schering Ag Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
US6022554A (en) * 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
ES2359973T3 (es) * 1998-03-19 2011-05-30 MERCK SHARP & DOHME CORP. Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
FR2770134B1 (fr) * 1998-10-28 2002-06-07 Delab Formulations solides ou semi-solides pour administration locale
US7767708B2 (en) * 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
US6953586B1 (en) * 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
WO2007011708A2 (fr) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent a revetement polymere renfermant de la rapamycine amorphe
EP1909973B1 (fr) 2005-07-15 2018-08-22 Micell Technologies, Inc. Enrobages polymeres renfermant de la poudre de medicament a morphologie commandee
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
US8852625B2 (en) 2006-04-26 2014-10-07 Micell Technologies, Inc. Coatings containing multiple drugs
ATE539102T1 (de) * 2006-10-31 2012-01-15 Surmodics Pharmaceuticals Inc Kugelförmige polymer-partikel
CN101711137B (zh) 2007-01-08 2014-10-22 米歇尔技术公司 具有可生物降解层的支架
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
US9433516B2 (en) 2007-04-17 2016-09-06 Micell Technologies, Inc. Stents having controlled elution
CA2721832C (fr) 2008-04-17 2018-08-07 Micell Technologies, Inc. Stents a couches bioabsorbables
CA2721927C (fr) 2008-04-21 2014-01-28 Otonomy, Inc. Preparations auriculaires de traitement de maladies et etats otiques
JP2011528275A (ja) 2008-07-17 2011-11-17 ミセル テクノロジーズ，インク． 薬物送達医療デバイス
US20100120811A1 (en) 2008-07-17 2010-05-13 Peter Hanson Long-acting injectable analgesic formulations for animals
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
US10092580B2 (en) 2008-07-21 2018-10-09 Otonomy, Inc. Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
US8784870B2 (en) * 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
CN102481195B (zh) 2009-04-01 2015-03-25 米歇尔技术公司 涂覆支架
EP2531140B1 (fr) 2010-02-02 2017-11-01 Micell Technologies, Inc. Endoprothèse et système de pose d'endoprothèse avec une capacité améliorée de pose
WO2011133655A1 (fr) 2010-04-22 2011-10-27 Micell Technologies, Inc. Endoprothèses et autres dispositifs ayant un revêtement de matrice extracellulaire
CN103313702A (zh) * 2010-06-30 2013-09-18 赢创有限公司 用于热不稳定及其它的生物活性剂的植入物的制备方法和由该方法制备的植入物
EP2593039B1 (fr) 2010-07-16 2022-11-30 Micell Technologies, Inc. Dispositif médical d'administration de médicament
CA2841360A1 (fr) 2011-07-15 2013-01-24 Micell Technologies, Inc. Dispositif medical d'administration de medicament
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
ES2659159T3 (es) * 2011-12-02 2018-03-14 Merial, Inc. Formulaciones de moxidectina inyectable de acción prolongada y nuevas formas cristalinas de moxidectina
WO2014165264A1 (fr) 2013-03-12 2014-10-09 Micell Technologies, Inc. Implants biomédicaux bioabsorbables
KR102079613B1 (ko) 2013-05-15 2020-02-20 미셀 테크놀로지즈, 인코포레이티드 생흡수성 생체의학적 임플란트
US10226419B2 (en) 2014-09-08 2019-03-12 ProMed Pharma, LLC Methods for manufacturing implants
CA2993645A1 (fr) 2015-07-28 2017-02-02 Otonomy, Inc. Compositions d'agoniste trkb ou trkc et methodes de traitement de troubles otiques
CA3029281A1 (fr) 2016-06-29 2018-01-04 Otonomy, Inc. Formulations otiques a base de triglycerides et leurs utilisations
JP7497289B2 (ja) 2018-01-09 2024-06-10 ドンペ ファーマシューティシ エス．ピー．エー． 成長因子耳用製剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
CA1076480A (fr) * 1975-04-28 1980-04-29 John S. Kent Pellet a noyau inerte
US4191741A (en) * 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
US4293539A (en) * 1979-09-12 1981-10-06 Eli Lilly And Company Controlled release formulations and method of treatment
DK119884A (da) * 1983-03-18 1984-09-19 Lilly Co Eli Fast, cylindrisk, subkutan implantation og dens anvendelse
CA1236641A (fr) * 1984-07-06 1988-05-10 Motoaki Tanaka Copolymere d'acide lactique et d'acide glycolique et methode de production

Also Published As

Publication number Publication date
DE3778244D1 (de) 1992-05-21
CA1297020C (fr) 1992-03-10
EP0257369A1 (fr) 1988-03-02
ES2031096T3 (es) 1992-12-01
EP0257369B1 (fr) 1992-04-15
US4758435A (en) 1988-07-19
ATE74751T1 (de) 1992-05-15
AU599406B2 (en) 1990-07-19
NZ221390A (en) 1990-10-26
AU7672487A (en) 1988-02-18
GR3004370T3 (fr) 1993-03-31

Similar Documents

Publication Publication Date Title
ZA875897B (en) Estradiol implant composition and method for preparation
MY113488A (en) Compounds with growth hormone releasing properties
IL78826A (en) Precursor composition for the preparation of a biodegradable implant for the sustained release of an active material and such implants prepared therefrom
HUT58058A (en) Insecticidal composition and process for producing its active ingredient, 1-phenylimidazole derivatives
EP0643963A3 (fr) Dispositif bioérodable pour l'administration d'agents actifs.
CA2195119A1 (fr) Procedes et compositions d'anesthesie locale prolongee
HUT53873A (en) Insecticides comprising nitro compounds as active ingredient and process for producing the active ingredients
HUT54462A (en) Insecticidal and acaricidal compositions comprising azole derivatives as active ingredient and process for producing the active ingredient
HUT52083A (en) Herbicidal compositions comprising cyclohexenone oxymetres as active ingredient and process for producing the active ingredients
IL115138A (en) Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof
ES545744A0 (es) Un procedimiento para la preparacion de bencenoacetonitrilos.
HUT49591A (en) Plant growth regulating and fungicidal compositions comprising pyrimidine derivatives as active ingredient and process for producing the active ingredients
AU1840788A (en) Compositions having hair growth stimulating activity
IL79134A (en) Continuous release peptide implants for parenteral administration
HUT54358A (en) Process for producing substituted 1,3,5-triazinetrione derivatives and medical compositions comprising such compounds as active ingredient
IL106288A0 (en) Skin regenerating cosmetic compositions
EP1721617A3 (fr) Thérapeutiques dentaires comprenant de l'hormone parathyroide
HUT39962A (en) Herbicide compositions containing 2,4-diamino-pyrimidine derivatives as active ingredients and process for preparing the active ingredients
HUT63306A (en) Insecticidal compositions comprising guanide derivatives as active ingredient and process for producing the active ingredient
HUT48096A (en) Insecticides comprising 2-imino-1,3-dithiethane derivatives as active ingredient and process for producing the active ingredients
HUT46364A (en) Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient
HU900209D0 (en) Herbicid composition comprising n-phenyl-tetrahidroindazol-derivatives as active ingredient and process for preparation thereof
HUT64072A (en) Herbicidal and plant growth regulating compositions, process for producintg glycolaldehyde and lactic and derivatives used as active ingredient and process for using the compositions
EP0351876A3 (fr) Composition pour augmenter l'effet de vaccination
HUT46881A (en) Herbicides comprising cyclohexane-1,3,5-triones as active ingredient and process for producing the active ingredients